SCHEMBL3872898

SCHEMBL3872898

COc1cc2c(cc1C)c1cc(OC)c(C)cc1c1cc(OC)c(C)cc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
KDM4E B2RXH2 2/20 0.48
ATM Q13315 1/20 0.48
TAAR1 Q96RJ0 1/20 0.45
ACHE P22303 2/20 0.42
CYP19A1 P11511 1/20 0.39
NQO2 P16083 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CDK4 P11802 1/20 0.38
CCNA2 P20248 1/20 0.38
CCND1 P24385 1/20 0.38
CDK2 P24941 1/20 0.38
GSK3B P49841 1/20 0.38
CCNA1 P78396 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3873431 0.97 MAPT (0.47) MAPTKDM4EATMTAAR1ACHE
SCHEMBL3873017 0.97 MAPT (0.47) MAPTKDM4EATMTAAR1ACHE
SCHEMBL2954181 0.84 TAAR1 (0.56) MAPTKDM4EATMTAAR1ACHE
SCHEMBL12363876 0.82 MAPT (0.39) MAPTKDM4EATMTAAR1ACHE
SCHEMBL12330214 0.81 TAAR1 (0.48) MAPTKDM4EATMTAAR1ACHE
SCHEMBL1711296 0.81 CYP3A4 (0.53) MAPTKDM4EACHENQO2PDE3B
SCHEMBL29368836 0.81 CYP3A4 (0.53) MAPTKDM4EACHENQO2PDE3B
SCHEMBL12593193 0.79 KDM4E (0.46) MAPTKDM4EATMTAAR1MEN1
SCHEMBL12593179 0.79 HDAC3 (0.42) MAPTKDM4EATMTAAR1CYP19A1
SCHEMBL8269049 0.79 TAAR1 (0.52) MAPTKDM4EATMTAAR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed
WO-2005042613-A1 MULTIFUNCTIONAL MONOMERS CONTAINING BOUND MESOGENIC PORAGEN FORMING MOIETIES AND POLYARYLENE COMPOSITIONS THEREFROM DOW GLOBAL TECHNOLOGIES INC. (US) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom LRBA, CD74, BMP2 MAPT 4021/4885KDM4E 4789/4885ATM 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.